110 related articles for article (PubMed ID: 2852028)
1. High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma.
Mbidde EK; Selby PJ; Perren TJ; Dearnaley DP; Whitton A; Ashley S; Workman P; Bloom HJ; McElwain TJ
Br J Cancer; 1988 Dec; 58(6):779-82. PubMed ID: 2852028
[TBL] [Abstract][Full Text] [Related]
2. Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation.
Johnson DB; Thompson JM; Corwin JA; Mosley KR; Smith MT; de los Reyes RA; Daly MB; Petty AM; Lamaster D; Pierson WP
J Clin Oncol; 1987 May; 5(5):783-9. PubMed ID: 3553437
[TBL] [Abstract][Full Text] [Related]
3. High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme.
Hochberg FH; Parker LM; Takvorian T; Canellos GP; Zervas NT
J Neurosurg; 1981 Apr; 54(4):455-60. PubMed ID: 6259300
[TBL] [Abstract][Full Text] [Related]
4. Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma.
Phillips GL; Wolff SN; Fay JW; Herzig RH; Lazarus HM; Schold C; Herzig GP
J Clin Oncol; 1986 May; 4(5):639-45. PubMed ID: 3009725
[TBL] [Abstract][Full Text] [Related]
5. High-dose carmustine with autologous bone marrow transplantation for the adjuvant treatment of high-grade gliomas of the central nervous system.
Wolff SN; Phillips GL; Herzig GP
Cancer Treat Rep; 1987 Feb; 71(2):183-5. PubMed ID: 3026626
[TBL] [Abstract][Full Text] [Related]
6. High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas: benefit for selected patients.
Fernández-Hidalgo OA; Vanaclocha V; Vieitez JM; Aristu JJ; Rebollo J; Gúrpide A; Aramendía JM; Moreno-Palanques R; Martín-Algarra S; Subirá ML; Brugarolas A
Bone Marrow Transplant; 1996 Jul; 18(1):143-9. PubMed ID: 8832007
[TBL] [Abstract][Full Text] [Related]
7. High dose BCNU with autologous bone marrow rescue in the treatment of recurrent malignant gliomas.
Mortimer JE; Hewlett JS; Bay J; Livingston RB
J Neurooncol; 1983; 1(3):269-73. PubMed ID: 6088718
[TBL] [Abstract][Full Text] [Related]
8. High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients.
Durando X; Lemaire JJ; Tortochaux J; Van-Praagh I; Kwiatkowski F; Vincent C; Bailly C; Verrelle P; Irthum B; Chazal J; Bay JO
Bone Marrow Transplant; 2003 Apr; 31(7):559-64. PubMed ID: 12692621
[TBL] [Abstract][Full Text] [Related]
9. Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study.
Phillips GL; Fay JW; Herzig GP; Herzig RH; Weiner RS; Wolff SN; Lazarus HM; Karanes C; Ross WE; Kramer BS
Cancer; 1983 Nov; 52(10):1792-802. PubMed ID: 6354414
[TBL] [Abstract][Full Text] [Related]
10. High dose BCNU followed by autologous bone marrow infusion in glioblastoma multiforme.
Carella AM; Giordano D; Santini G; Frassoni F; Podestà M; Van Lint MT; Bacigalupo A; Nati S; Vimercati R; Occhini D; Bistolfi F; Lucarelli G; Lercari G; Marmont AM
Tumori; 1981 Oct; 67(5):473-5. PubMed ID: 6275588
[No Abstract] [Full Text] [Related]
11. Randomized trial of radiation therapy (RT) plus dibromodulcitol (DBD) versus RT plus BCNU in high grade astrocytoma.
Elliott TE; Dinapoli RP; O'Fallon JR; Krook JE; Earle JD; Morton RF; Levitt R; Tschetter LK; Scheithauer BW; Pfeifle DM; Twito DI; Nelimark RA
J Neurooncol; 1997 Jul; 33(3):239-50. PubMed ID: 9195495
[TBL] [Abstract][Full Text] [Related]
12. Long-term survivors of high-grade malignant astrocytomas.
Dara P; Slater LM; Talreja D; Armentrout SA
Med Pediatr Oncol; 1980; 8(2):187-91. PubMed ID: 6252428
[TBL] [Abstract][Full Text] [Related]
13. Pre-irradiation internal carotid artery BCNU in treatment of glioblastoma multiforme.
Bashir R; Hochberg FH; Linggood RM; Hottleman K
J Neurosurg; 1988 Jun; 68(6):917-9. PubMed ID: 2836567
[TBL] [Abstract][Full Text] [Related]
14. Sequential and adjuvant chemotherapy for malignant astrocytoma of the brain.
Kessinger A; Lemon HM; Foley JF
J Surg Oncol; 1978; 10(6):543-7. PubMed ID: 215846
[TBL] [Abstract][Full Text] [Related]
15. The chemotherapy of brain tumors. Clinical experience with carmustine (BCNU) and vincristine.
Fewer D; Wilson CB; Boldrey EB; Enot KJ; Powell MR
JAMA; 1972 Oct; 222(5):549-52. PubMed ID: 4343318
[No Abstract] [Full Text] [Related]
16. Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy.
Raizer JJ; Malkin MG; Kleber M; Abrey LE
Neuro Oncol; 2004 Jul; 6(3):247-52. PubMed ID: 15279717
[TBL] [Abstract][Full Text] [Related]
17. Autologous bone-marrow transplantation: host effects of high-dose BCNU.
Takvorian T; Parker LM; Hochberg FH; Canellos GP
J Clin Oncol; 1983 Oct; 1(10):610-20. PubMed ID: 6366127
[TBL] [Abstract][Full Text] [Related]
18. MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblastoma treated with carmustine wafers.
Gutenberg A; Bock HC; Brück W; Doerner L; Mehdorn HM; Roggendorf W; Westphal M; Felsberg J; Reifenberger G; Giese A
Br J Neurosurg; 2013 Dec; 27(6):772-8. PubMed ID: 23662801
[TBL] [Abstract][Full Text] [Related]
19. High-dose BCNU with ABMT followed by radiation therapy in the treatment of supratentorial glioblastoma multiforme.
Linassier C; Benboubker L; Velut S; Calais G; Saudeau D; Jan M; Autret A; Berger C; Biron P; Colombat P
Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S69-72. PubMed ID: 8899180
[No Abstract] [Full Text] [Related]
20. Nursing management of the patient receiving high-dose BCNU with autologous bone marrow harvest.
Gamel-Bentzel C
J Neurosurg Nurs; 1982 Apr; 14(2):98-102. PubMed ID: 6288899
[No Abstract] [Full Text] [Related]
[Next] [New Search]
